Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer (PembroMab)

Clinical Trial ID NCT02318901

PubWeight™ 7.16^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02318901

Top papers